Company Financials

Clinigen Group plc Financials

Pound sterling

business Clinigen Group plc Company Profile

Main Stock Listing

LSE: CLIN

Market Capitalization £1.22 Billion as of April 1, 2022

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 64.69
Forward PE 0.36
Price to Sales TTM £2.18
Price to Book MRQ £270.55
Enterprise to Revenue 2.70
Enterprise to EBITDA 14.46

Financial Reports as of Dec. 31, 2021

Financials

Fiscal Year Ends 2021-06-30
Most Recent Quarter 2021-12-31
Profit Margin 3.45%
Operating Margin 10.27%
Return on Assets TTM 3.51%
Return on Equity TTM 6.32%

Income Statement

Revenue TTM £565,600,000
Revenue per Share TTM £4.25
Quarterly Revenue Growth 17.40%
Gross Profit TTM £198,000,000
EBITDA £118,100,000
Net Income to Common TTM £28,200,000
Diluted EPS TTM £14.30
Quarterly Earnings Growth YoY -60.00%

Balance Sheet

Total Cash MRQ £117,500,000
Total Cash per Share MRQ £0.88
Total Debt MRQ £
Total Debt to Equity MRQ 90.77
Current Ratio MRQ 1.89
Book Value per Share MRQ £3.42

Cash Flow

Operating Cash Flow TTM £90,800,000
Levered Free Cash Flow TTM £86,037,504

CLIN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 133,367,000
Float Shares 111,282,248
Avg 10 Volume 1,277,554
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 11.73%
% Held by Institutions 77.41%

Stock Price Summary

Beta 1.44
Fifty Two Week Low £9.25
Fifty Two Week High £948.05
Fifty Two Week Change -0.99%
Day 50 MA £899.45
Day 200 MA £745.26

Dividends and Splits

Forward Annual Dividend Rate £10.92
Forward Annual Dividend Yield 1.18%
Trailing Annual Dividend Rate £7.61
Trailing Annual Dividend Yield 0.82%
Payout Ratio 36.76%
Dividend Date
Ex Dividend Date 2021-12-02
Last Split Factor
Last Split Date